title: [The use of enterosorption and plasmapheresis during the chemotherapy of lung cancer patients].
abstract: As many as 44 patients with stage IIIB and IV carcinoma of the lung (n = 27 and 17 respectively) were studied for clinical and laboratory manifestations of endogenous intoxication syndrome during the administration of CAPF chemotherapy treatments. The use for detoxicating purposes of siliceous enterosorbents and plasmapheresis both alone and combined resulted in alleviation of gastrointestinal and hematological complications and permitted improving the quality of the patients' lives.
authors.forename: T H
authors.initials: TH
authors.lastname: Fetsych
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D016061:Enterosorption / Q000379:methods / Q000706:statistics & numerical data; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010956:Plasmapheresis / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D005472:Fluorouracil